Archives of Head and Neck Surgery
https://archivesheadnecksurgery.com/article/doi/10.4322/ahns.2018.0093
Archives of Head and Neck Surgery
Original Article Thyroid diseases and tumors

Noninvasive follicular thyroid neoplasm with papillary nuclear characteristics: Clinicopathologic features and follow-up

Oscar Brunás, José Luis Novelli, Stella Batallés

Downloads: 2
Views: 248

Abstract

Introduction: A lesion structurally encapsulated or with noninfiltrating expansive edges, follicular pattern growth, 40 mm). All were treated with total thyroidectomy and 20/21 received an ablative dose of I131. At the follow-up (>5 years on average), there were no cases of local, regional or systemic, biochemical or structural recurrences. Comparing the NIFTP and non-NIFTP, similar tumor features were found for the age, gender, maximum tumor dimension, surgical extension, and iodine ablation, median follow-up and recurrent events; p>0.05, without statistical significance. Conclusion: Twenty percent of follicular variant papillary carcinomas now reclassified as NIFTP were overtreated and overcontrolled as if they were PTC; no recurrent events or deaths were detected. We cannot distinguish whether the good prognosis is due to the nature of these neoplasms or to overtreatment.

Keywords

apillary thyroid carcinoma; noninvasive follicular thyroid neoplasm with papillary nuclear features; recurrent tumor; overtreatment; over following-up

References

1. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023-9. http://dx.doi.org/10.1001/jamaoncol.2016.0386. PMid:27078145.

2. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol. 2016;29(7):698-707. http://dx.doi.org/10.1038/modpathol.2016.65. PMid:27102347.

3. Kolata G. It’s not cancer: doctors reclassify a thyroid tumor. The New York Times [Internet]. 2016 apr. 15 [cited 2018 Aug 22]. Health. Available from: https://www.nytimes.com/2016/04/15/health/thyroid-tumor-cancer-reclassification.html

4. No es cáncer: la ciencia recategorizó un tumor de tiroides. Diario Infobae [Internet]. 2016 apr. 16 [cited 2018 Aug 22]. Ciencia. Available from: https://www.infobae.com/2016/04/17/1804832-no-es-cancer-la-ciencia-recategorizo-un-tumor-tiroides

5. Román V. Un tipo de tumor de tiroides dejará de tratarse como cáncer. Diario Clarin [Internet]. 2016 apr. 20 [cited 2018 Aug 22]. Sociedad. Available from: https://www.clarin.com/sociedad/tumor-tiroides-dejara-tratarse-cancer_0_41GuzhJl-.html

6. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD. American thyroid association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):481-3. http://dx.doi.org/10.1089/thy.2016.0628. PMid:28114862.

7. Alves VA, Kakudo K, LiVolsi V, Lloyd RV, Nikiforov YE, Nosé V, Papotti M, Thompson LDR. Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): achieving better agreement by refining diagnostic criteria. Clinics. 2018;73:e576. http://dx.doi.org/10.6061/clinics/2018/e576. PMid:29791602.

8. Titus K. For certain thyroid lesions, the shift is on. CAP Today. 2016;30(7):1-30.

9. Piana S, Frasoldati A, Felice E, Gardini G, Tallini G, Rosai J. Encapsulated welldifferentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010;34(6):868-72. http://dx.doi.org/10.1097/PAS.0b013e3181dbee07. PMid:20463572.

10. Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein R. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Thyroid. 2017;27(4):512-7. http://dx.doi.org/10.1089/thy.2016.0649. PMid:28136139.

11. Ganly I, Wang L, Tuttle RM, Katabi N, Ceballos GA, Harach HR, Ghossein R. Invasion rather than nuclear features correlates without come in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum Pathol. 2015;46(5):657-64. http://dx.doi.org/10.1016/j.humpath.2015.01.010. PMid:25721865.

12. Pitoia F, Jerkovich F, Urciuoli C, Falcón F, Lima AP. Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer. Arch Endocrinol Metab. 2018;62(2):157-63. PMid:29641733.

13. Wong KS, Strickland KC, Angell TE, Nehs MA, Alexander EK, Cibas ES, Krane JF, Howitt BE, Barletta JA. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas. Endocr Pathol. 2017;28(2):171-6. http://dx.doi.org/10.1007/s12022-017-9476-5. PMid:28271380.

14. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol. 2016;29(7):698-707. http://dx.doi.org/10.1038/modpathol.2016.65. PMid:27102347.

15. Baloch ZW, LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol. 2007;60(3):244-50. http://dx.doi.org/10.1136/jcp.2006.038604. PMid:16798933.

16. Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, Pusztaszeri MP, Van den Bussche CJ, Gourmaud J, Vaickus LJ, Baloch ZW. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 2016;124(3):181-7. http://dx.doi.org/10.1002/cncy.21631. PMid:26457584.

17. Bizzarro T, Martini M, Capodimonti S, Straccia P, Lombardi CP, Pontecorvi A, Larocca LM, Rossi ED. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer Cytopathol. 2016;124(10):699-710. http://dx.doi.org/10.1002/cncy.21777. PMid:27717284.

18. Zhao L, Dias-Santagata D, Sadow PM, Faquin WC. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol. 2017;125(5):323-31. http://dx.doi.org/10.1002/cncy.21839. PMid:28192645.

19. Brandler TC, Zhou F, Liu CZ, Cho M, Lau RP, Simsir A, Patel KN, Sun W. Can Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features Be Distinguished From Classic Papillary Thyroid Carcinoma and Follicular Adenomas by Fine-Needle Aspiration? Cancer Cytopathol. 2017;125(6):378-88. http://dx.doi.org/10.1002/cncy.21848. PMid:28296267.

20. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA. etal. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23(9):1191-200. http://dx.doi.org/10.1038/modpathol.2010.112. PMid:20526288.

21. Agrawal N, Akbani R, Aksoy BA, Ally A, Arachchi H, Asa SL, Auman JT, Balasundaram M, Balu S, Baylin SB, Behera M, Bernard B, Beroukhim R, Bishop JA, Black AD, Bodenheimer T, Boice L, Bootwalla MS, Bowen J, Bowlby R, Bristow CA, Brookens R, Brooks D, Bryant R, Buda E, Butterfield YSN, Carling T, Carlsen R, Carter SL, Carty SE, Chan TA, Chen AY, Cherniack AD, Cheung D, Chin L, Cho J, Chu A, Chuah E, Cibulskis K, Ciriello G, Clarke A, Clayman GL, Cope L, Copland JA, Covington K, Danilova L, Davidsen T, Demchok JA, DiCara D, Dhalla N, Dhir R, Dookran SS, Dresdner G, Eldridge J, Eley G, El-Naggar AK, Eng S, Fagin JA, Fennell T, Ferris RL, Fisher S, Frazer S, Frick J, Gabriel SB, Ganly I, Gao J, Garraway LA, Gastier-Foster JM, Getz G, Gehlenborg N, Ghossein R, Gibbs RA, Giordano TJ, Gomez-Hernandez K, Grimsby J, Gross B, Guin R, Hadjipanayis A, Harper HA, Hayes DN, Heiman DI, Herman JG, Hoadley KA, Hofree M, Holt RA, Hoyle AP, Huang FW, Huang M, Hutter CM, Ideker T, Iype L, Jacobsen A, Jefferys SR, Jones CD, Jones SJM, Kasaian K, Kebebew E, Khuri FR, Kim J, Kramer R, Kreisberg R, Kucherlapati R, Kwiatkowski DJ, Ladanyi M, Lai PH, Laird PW, Lander E, Lawrence MS, Lee D, Lee E, Lee S, Lee W, Leraas KM, Lichtenberg TM, Lichtenstein L, Lin P, Ling S, Liu J, Liu W, Liu Y, LiVolsi VA, Lu Y, Ma Y, Mahadeshwar HS, Marra MA, Mayo M, McFadden DG, Meng S, Meyerson M, Mieczkowski PA, Miller M, Mills G, Moore RA, Mose LE, Mungall AJ, Murray BA, Nikiforov YE, Noble MS, Ojesina AI, Owonikoko TK, Ozenberger BA, Pantazi A, Parfenov M, Park PJ, Parker JS, Paull EO, Pedamallu CS, Perou CM, Prins JF, Protopopov A, Ramalingam SS, Ramirez NC, Ramirez R, Raphael BJ, Rathmell WK, Ren X, Reynolds SM, Rheinbay E, Ringel MD, Rivera M, Roach J, Robertson AG, Rosenberg MW, Rosenthal M, Sadeghi S, Saksena G, Sander C, Santoso N, Schein JE, Schultz N, Schumacher SE, Seethala RR, Seidman J, Senbabaoglu Y, Seth S, Sharpe S, Shaw KRM, Shen JP, Shen R, Sherman S, Sheth M, Shi Y, Shmulevich I, Sica GL, Simons JV, Sinha R, Sipahimalani P, Smallridge RC, Sofia HJ, Soloway MG, Song X, Sougnez C, Stewart C, Stojanov P, Stuart JM, Sumer SO, Sun Y, Tabak B, Tam A, Tan D, Tang J, Tarnuzzer R, Taylor BS, Thiessen N, Thorne L, Thorsson V, Tuttle RM, Umbricht CB, Van Den Berg DJ, Vandin F, Veluvolu U, Verhaak RGW, Vinco M, Voet D, Walter V, Wang Z, Waring S, Weinberger PM, Weinhold N, Weinstein JN, Weisenberger DJ, Wheeler D, Wilkerson MD, Wilson J, Williams M, Winer DA, Wise L, Wu J, Xi L, Xu AW, Yang L, Yang L, Zack TI, Zeiger MA, Zeng D, Zenklusen JC, Zhao N, Zhang H, Zhang J, Zhang JJ, Zhang W, Zmuda E, Zou L, Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676-90. http://dx.doi.org/10.1016/j.cell.2014.09.050. PMid:25417114.

22. Howitt BE, Paulson VA, Barletta JA. Absence of BRAF V600E in non-infiltrative, noninvasive follicular variant of papillary thyroid carcinoma. Histopathology. 2015;67(4):579-82. http://dx.doi.org/10.1111/his.12680. PMid:25736029

5cd9bc570e8825937986c886 archives Articles
Links & Downloads

Arch. Head Neck Surg.

Share this page
Page Sections